Author

Amy R. Dwyer

The University of AdelaideORCID 0000-0002-4422-1433Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Anthony BergeroniD· 1 shared Carlos Jesus Perez KerkvlietiD· 1 shared Carol Ann LangeiD· 1 shared Ebtihal H MustafaiD· 1 shared Ellie Piepgras· 1 shared Gaëtan Marie MacGroganiD· 1 shared Geoffrey L. GreeneiD· 1 shared Geraldine Laven‐LawiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anthony BergeronORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer Biologynpj Breast CancerPeer-reviewedApr 7, 2026

Progesterone receptors drive advanced breast cancer phenotypes including circulating tumor- and stem-like cell expansion in the context of ESR1 mutation

Thu Ha Truong, Noelle E. Gillis, Amy R. Dwyer…·Carol Ann Lange

This study shows that progesterone receptors (PR) interact with mutant ESR1 variants in ER+ breast cancer, driving CSC expansion and UPR activation, which can be targeted therapeutically.

DOI 10.1038/s41523-026-00939-8

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 5, 2025

The transcription factor AP-2β defines active enhancers conferring molecular apocrine cell identity in breast cancer

Ebtihal H Mustafa, Geraldine Laven‐Law, Jean M. Winter…·Theresa E. Hickey

This study identifies AP-2β as a key regulator of active enhancers in molecular apocrine breast cancer, linking its expression to cell identity and proliferation.

DOI 10.1101/2025.07.05.663274

humanChIP-seq

𝕏 PostBluesky